Literature DB >> 14967766

The relationship between diffuse axonal damage and fatigue in multiple sclerosis.

Maria Carmela Tartaglia1, Sridar Narayanan, Simon J Francis, Antonio Carlos Santos, Nicola De Stefano, Yves Lapierre, Douglas L Arnold.   

Abstract

BACKGROUND: Fatigue is a common and distressing symptom for patients with multiple sclerosis (MS). There is growing evidence that fatigue in MS has a central nervous system component. We hypothesized that diffuse cerebral axonal damage could be associated with fatigue and used proton magnetic resonance spectroscopy to noninvasively measure axonal damage or loss in the brains of patients with MS.
OBJECTIVE: To assess the strength of the relationship between central brain N-acetylaspartate and fatigue.
DESIGN: Data from 73 patients who had undergone proton magnetic resonance spectroscopy imaging and completed the Fatigue Severity Scale questionnaire were analyzed.
RESULTS: The N-acetylaspartate-creatine ratio (NAA/Cr) was significantly lower in the high-fatigue group than the low-fatigue group (mean +/- SD, 2.69 +/- 0.29 and 2.99 +/- 0.33, respectively. P =.003). Independent of the Kurtzke Expanded Disability Status Scale, T2 lesion volume, age, and disease duration, NAA/Cr was significantly lower in the high-fatigue group as compared with the low-fatigue group. There was a statistically significant linear correlation between the Fatigue Severity Scale scores and NAA/Cr (Spearman rank rho = -0.361, P =.02).
CONCLUSIONS: The results of this study, combined with those of others, suggest that widespread axonal dysfunction is associated with fatigue in MS. Increased recruitment of cortical areas and pathways in response to brain injury may be responsible for the patient's sense that the effort required to perform actions is disproportionately high.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14967766     DOI: 10.1001/archneur.61.2.201

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  46 in total

Review 1.  Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment.

Authors:  Tiffany J Braley; Ronald D Chervin
Journal:  Sleep       Date:  2010-08       Impact factor: 5.849

2.  Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue.

Authors:  I Specogna; F Casagrande; A Lorusso; M Catalan; A Gorian; L Zugna; R Longo; M Zorzon; M Naccarato; G Pizzolato; M Ukmar; M A Cova
Journal:  Radiol Med       Date:  2012-06-22       Impact factor: 3.469

Review 3.  Magnetic resonance spectroscopy in the monitoring of multiple sclerosis.

Authors:  Ponnada A Narayana
Journal:  J Neuroimaging       Date:  2005       Impact factor: 2.486

4.  Influence of task complexity during coordinated hand and foot movements in MS patients with and without fatigue. A kinematic and functional MRI study.

Authors:  Maria Assunta Rocca; Roberto Gatti; Federica Agosta; Paola Broglia; Paolo Rossi; Elisa Riboldi; Manuela Corti; Giancarlo Comi; Massimo Filippi
Journal:  J Neurol       Date:  2009-03-06       Impact factor: 4.849

5.  fMRI changes in relapsing-remitting multiple sclerosis patients complaining of fatigue after IFNbeta-1a injection.

Authors:  Maria A Rocca; Federica Agosta; Bruno Colombo; Domenico M Mezzapesa; Andrea Falini; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2007-05       Impact factor: 5.038

Review 6.  4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review.

Authors:  Henrik Boye Jensen; Mads Ravnborg; Ulrik Dalgas; Egon Stenager
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

Review 7.  Fatigue versus activity-dependent fatigability in patients with central or peripheral motor impairments.

Authors:  Bruce H Dobkin
Journal:  Neurorehabil Neural Repair       Date:  2008 Mar-Apr       Impact factor: 3.919

8.  The basal ganglia: a substrate for fatigue in multiple sclerosis.

Authors:  N Téllez; J Alonso; J Río; M Tintoré; C Nos; X Montalban; A Rovira
Journal:  Neuroradiology       Date:  2007-10-23       Impact factor: 2.804

9.  Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis.

Authors:  Khalil Kanjwal; Beverly Karabin; Yousuf Kanjwal; Blair P Grubb
Journal:  Int J Med Sci       Date:  2010-03-11       Impact factor: 3.738

10.  3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis.

Authors:  Mohit Neema; Daniel Goldberg-Zimring; Zachary D Guss; Brian C Healy; Charles R G Guttmann; Maria K Houtchens; Howard L Weiner; Mark A Horsfield; David B Hackney; David C Alsop; Rohit Bakshi
Journal:  Neuroimage       Date:  2009-03-10       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.